However, no significant difference in the frequency of anti-sp100 was observed between AMA-positive and AMA-negative PBC patients, indicating that anti-sp100 is unlikely to serve as a complementary serological marker for PBC in AMA-negative patients [90]. Here, SP100 is linked to primary biliary cholangitis.